Characteristics Associated With Growth Differentiation Factor 15 in Heart Failure With Preserved Ejection Fraction and the Impact of Pirfenidone

BACKGROUND: Growth differentiation factor 15 (GDF‐15) is elevated in heart failure with preserved ejection fraction and is associated with adverse outcome, but its relationship with myocardial fibrosis and other characteristics remains unclear. We sought to evaluate the effect of pirfenidone, a nove...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewis, Gavin A., Rosala‐Hallas, Anna, Dodd, Susanna, Schelbert, Erik B., Williams, Simon G., Cunnington, Colin, McDonagh, Theresa, Miller, Christopher A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707842/
https://www.ncbi.nlm.nih.gov/pubmed/35861823
http://dx.doi.org/10.1161/JAHA.121.024668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707842/
https://www.ncbi.nlm.nih.gov/pubmed/35861823
http://dx.doi.org/10.1161/JAHA.121.024668

Ejemplares similares